Enzalutamide
-
BDR Pharmaceuticals launches BDENZA oral solution for prostate cancer treatment
The oral solution is gentle on the stomach, avoiding issues like nausea BDR Pharmaceuticals has introduced BDENZA, the world’s first…
Read More » -
BDR Pharma launches prostate cancer drug Enzalutamide 160 mg
The objective behind the launch of Enzalutamide 160 mg is to ensure better efficacy, minimum side effects BDR Pharmaceuticals has…
Read More »